Lorraine T Dean1,2, Naomi Greene3, Mary Anne Adams4, Sophia R Geffen5,6, Jowanna Malone1, Kristi Tredway1, Tonia Poteat1,7. 1. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 2. Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. 3. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 4. ZAMI NOBLA: National Organization of Black Lesbians on Aging, East Point, Georgia, USA. 5. Center for Health Equity Education & Advocacy, Cambridge Health Alliance, Cambridge, Massachusetts, USA. 6. Johns Hopkins School of Nursing, Baltimore, Maryland, USA. 7. Department of Social Medicine, University of North Carolina Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
OBJECTIVE: Healthcare system distrust (HCSD) has been linked to poor breast cancer outcomes. Previous HSCD analyses have focused on Black-White disparities; however, focusing only on race ignores the complex set of factors that form identity. We quantified the contributions of race and sexual minority (SM) identity to HCSD among US women who had received breast cancer screening. METHODS: This cross-sectional study used intersectionality decomposition methods to assess the degree to which racial and SM identity contributed to disparate responses to the validated 9-item HCSD Scale. The sample included online survey participants identifying as a Black or White woman living in the US, with a self-reported abnormal breast cancer screening result in the past 24 months and/or breast cancer diagnosis since 2011. RESULTS: Of 649 participants, 49.4% of Black SM women (n = 85) were in the highest HCSD tertile, followed by 37.4% of White SM women (n = 123), 24.4% of Black heterosexual women (n = 156), and 19% of White heterosexual women. Controlling for age, 72% of the disparity in HCSD between Black SM women and White heterosexual women was due to SM status, 23% was due to racial identity, and 3% was due to both racial and SM identity. CONCLUSIONS: SM identity emerged as the largest driver of HCSD disparities; however, the combined racial and SM disparity persisted. Excluding sexual identity in HCSD studies may miss an important contributor. Interventions designed to increase the HCS's trustworthiness at the provider and system levels should address both racism and homophobia.
OBJECTIVE: Healthcare system distrust (HCSD) has been linked to poor breast cancer outcomes. Previous HSCD analyses have focused on Black-White disparities; however, focusing only on race ignores the complex set of factors that form identity. We quantified the contributions of race and sexual minority (SM) identity to HCSD among US women who had received breast cancer screening. METHODS: This cross-sectional study used intersectionality decomposition methods to assess the degree to which racial and SM identity contributed to disparate responses to the validated 9-item HCSD Scale. The sample included online survey participants identifying as a Black or White woman living in the US, with a self-reported abnormal breast cancer screening result in the past 24 months and/or breast cancer diagnosis since 2011. RESULTS: Of 649 participants, 49.4% of Black SM women (n = 85) were in the highest HCSD tertile, followed by 37.4% of White SM women (n = 123), 24.4% of Black heterosexual women (n = 156), and 19% of White heterosexual women. Controlling for age, 72% of the disparity in HCSD between Black SM women and White heterosexual women was due to SM status, 23% was due to racial identity, and 3% was due to both racial and SM identity. CONCLUSIONS: SM identity emerged as the largest driver of HCSD disparities; however, the combined racial and SM disparity persisted. Excluding sexual identity in HCSD studies may miss an important contributor. Interventions designed to increase the HCS's trustworthiness at the provider and system levels should address both racism and homophobia.
Authors: L Ebony Boulware; Lisa A Cooper; Lloyd E Ratner; Thomas A LaVeist; Neil R Powe Journal: Public Health Rep Date: 2003 Jul-Aug Impact factor: 2.792
Authors: Rebecca Selove; Barbara Kilbourne; Mary Kay Fadden; Maureen Sanderson; Maya Foster; Regina Offodile; Baqar Husaini; Charles Mouton; Robert S Levine Journal: Womens Health Issues Date: 2016-10-20
Authors: Lisa A Eaton; Daniel D Driffin; Christopher Kegler; Harlan Smith; Christopher Conway-Washington; Denise White; Chauncey Cherry Journal: Am J Public Health Date: 2015-02 Impact factor: 9.308
Authors: Lorraine T Dean; Shadiya L Moss; Anne Marie McCarthy; Katrina Armstrong Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-09-29 Impact factor: 4.254
Authors: Katie E J Hann; Madeleine Freeman; Lindsay Fraser; Jo Waller; Saskia C Sanderson; Belinda Rahman; Lucy Side; Sue Gessler; Anne Lanceley Journal: BMC Public Health Date: 2017-05-25 Impact factor: 3.295